These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1053 related articles for article (PubMed ID: 27629548)

  • 21. The management of cancer patients with heart disease.
    Kawecka-Jaszcz K; Bednarek A
    Przegl Lek; 2012; 69(2):82-6. PubMed ID: 22768420
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Left Ventricular Dysfunction and Chemotherapeutic Agents.
    Clasen SC; Wald JW
    Curr Cardiol Rep; 2018 Mar; 20(4):20. PubMed ID: 29520629
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Emergence of cardio-oncology.
    Nebigil CG; Désaubry L
    Ann Pharm Fr; 2018 Nov; 76(6):504-506. PubMed ID: 30075937
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Natriuretic peptide-based screening and collaborative care for heart failure: the STOP-HF randomized trial.
    Ledwidge M; Gallagher J; Conlon C; Tallon E; O'Connell E; Dawkins I; Watson C; O'Hanlon R; Bermingham M; Patle A; Badabhagni MR; Murtagh G; Voon V; Tilson L; Barry M; McDonald L; Maurer B; McDonald K
    JAMA; 2013 Jul; 310(1):66-74. PubMed ID: 23821090
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cardiotoxicity of anticancer treatments: Epidemiology, detection, and management.
    Curigliano G; Cardinale D; Dent S; Criscitiello C; Aseyev O; Lenihan D; Cipolla CM
    CA Cancer J Clin; 2016 Jul; 66(4):309-25. PubMed ID: 26919165
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Benefits of antihypertensive medications for anthracycline- and trastuzumab-induced cardiotoxicity in patients with breast cancer: Insights from recent clinical trials.
    Rygiel K
    Indian J Pharmacol; 2016; 48(5):490-497. PubMed ID: 27721532
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Angiotensin II-Receptor Inhibition With Candesartan to Prevent Trastuzumab-Related Cardiotoxic Effects in Patients With Early Breast Cancer: A Randomized Clinical Trial.
    Boekhout AH; Gietema JA; Milojkovic Kerklaan B; van Werkhoven ED; Altena R; Honkoop A; Los M; Smit WM; Nieboer P; Smorenburg CH; Mandigers CM; van der Wouw AJ; Kessels L; van der Velden AW; Ottevanger PB; Smilde T; de Boer J; van Veldhuisen DJ; Kema IP; de Vries EG; Schellens JH
    JAMA Oncol; 2016 Aug; 2(8):1030-7. PubMed ID: 27348762
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prospective surveillance and management of cardiac toxicity and health in breast cancer survivors.
    Schmitz KH; Prosnitz RG; Schwartz AL; Carver JR
    Cancer; 2012 Apr; 118(8 Suppl):2270-6. PubMed ID: 22488701
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Use of dexrazoxane as a cardioprotectant in patients receiving doxorubicin or epirubicin chemotherapy for the treatment of cancer. The Provincial Systemic Treatment Disease Site Group.
    Seymour L; Bramwell V; Moran LA
    Cancer Prev Control; 1999 Apr; 3(2):145-59. PubMed ID: 10474762
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cardio-oncology: a new and developing sector of research and therapy in the field of cardiology.
    Kostakou PM; Kouris NT; Kostopoulos VS; Damaskos DS; Olympios CD
    Heart Fail Rev; 2019 Jan; 24(1):91-100. PubMed ID: 30073443
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [ANMCO/AICO/AIOM Consensus document: Clinical and management pathways in cardio-oncology].
    Tarantini L; Gulizia MM; Di Lenarda A; Maurea N; Abrignani MG; Bisceglia I; Bovelli D; De Gennaro L; Del Sindaco D; Macera F; Parrini I; Radini D; Russo G; Scardovi AB; Inno A
    G Ital Cardiol (Rome); 2017 Jan; 18(1):14-66. PubMed ID: 28287211
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The Patient Remote Intervention and Symptom Management System (PRISMS) - a Telehealth- mediated intervention enabling real-time monitoring of chemotherapy side-effects in patients with haematological malignancies: study protocol for a randomised controlled trial.
    Breen S; Ritchie D; Schofield P; Hsueh YS; Gough K; Santamaria N; Kamateros R; Maguire R; Kearney N; Aranda S
    Trials; 2015 Oct; 16():472. PubMed ID: 26481873
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Treatment-related cardiotoxicity in childhood cancer survivors: Risk factors and follow-up].
    Fresneau B; Fayech C; Butel T; Haddy N; Valteau-Couanet D; Ou P
    Rev Med Interne; 2017 Feb; 38(2):125-132. PubMed ID: 27639916
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cardiac toxicity from systemic cancer therapy: a comprehensive review.
    Curigliano G; Mayer EL; Burstein HJ; Winer EP; Goldhirsch A
    Prog Cardiovasc Dis; 2010; 53(2):94-104. PubMed ID: 20728696
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Utility of tissue Doppler and strain rate imaging in the early detection of trastuzumab and anthracycline mediated cardiomyopathy.
    Jassal DS; Han SY; Hans C; Sharma A; Fang T; Ahmadie R; Lytwyn M; Walker JR; Bhalla RS; Czarnecki A; Moussa T; Singal PK
    J Am Soc Echocardiogr; 2009 Apr; 22(4):418-24. PubMed ID: 19269133
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The Role of Biomarkers in Cardio-Oncology.
    Ananthan K; Lyon AR
    J Cardiovasc Transl Res; 2020 Jun; 13(3):431-450. PubMed ID: 32642841
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Left ventricular end-diastolic volume as early indicator of trastuzumab-related cardiotoxicity in HER2+ breast cancer patients: results from a single-center retrospective study.
    Bergamini C; Torelli F; Ghiselli L; Rossi A; Trevisani L; Vinco G; Truong S; Benfari G; LA Russa F; Golia G; Molino A; Vassanelli C
    Minerva Cardioangiol; 2017 Jun; 65(3):278-287. PubMed ID: 27886160
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cardio-oncology - strategies for management of cancer-therapy related cardiovascular disease.
    Totzeck M; Schuler M; Stuschke M; Heusch G; Rassaf T
    Int J Cardiol; 2019 Apr; 280():163-175. PubMed ID: 30661849
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prevention and Treatment of Cardiac Dysfunction in Breast Cancer Survivors.
    Fabian C
    Adv Exp Med Biol; 2015; 862():213-30. PubMed ID: 26059938
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Anthracycline-related cardiotoxicity in childhood cancer survivors.
    Lipshultz SE; Karnik R; Sambatakos P; Franco VI; Ross SW; Miller TL
    Curr Opin Cardiol; 2014 Jan; 29(1):103-12. PubMed ID: 24284979
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 53.